A recent study by the Tufts Center for the Study of Drug Development found that how drug developers organize their companies affects operational and financial performance. The research, developed by Tufts CSDD and PRTM, an operations management consulting firm, found that: globally positioned operations correlate with higher sales per product, annual number of approvals, and levels of operating efficiency; operations with diverse product portfolios correlate with higher levels of operating effic...